Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CABOTEGRAVIR”

113 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 113 results

Early research (Phase 1)Study completedNCT03149848
What this trial is testing

Effect of Rifabutin on the Pharmacokinetics of Oral Cabotegravir in Healthy Subjects

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 15
Not applicableNot Yet RecruitingNCT07516548
What this trial is testing

Pharmacokinetic Study of Long-acting Antiretrovirals and Contraceptives in HIV

Who this might be right for
HIV InfectionsContraceptionDrug-drug Interaction+2 more
University of Alabama at Birmingham 105
Not applicableLooking for participantsNCT06834113
What this trial is testing

Impact of Pain From Injectables Antiretroviral Treatments in HIV-1 Patients Based on the Injection Site (Ventrogluteal or Dorsogluteal) and the Use or Non-use of Virtual Reality Headset

Who this might be right for
HIV I InfectionInjection Pain
Centre Hospitalier Régional d'Orléans 120
Early research (Phase 1)Study completedNCT02027454
What this trial is testing

Study to Evaluate the Effect of GSK1265744 on Cardiac Conduction

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 42
Early research (Phase 1)Study completedNCT02345707
What this trial is testing

Relative Bioavailability Study of Phase III Tablet Formulation of Cabotegravir

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 37
Testing effectiveness (Phase 2)Study completedNCT03739996
What this trial is testing

Long-Acting Cabotegravir Plus VRC-HIVMAB075-00-AB (VRC07-523LS) for Viral Suppression in Adults Living With HIV-1

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 75
Early research (Phase 1)Active Not RecruitingNCT06786520
What this trial is testing

Evaluate the Pharmacokinetics, Safety, and Tolerability of Cabotegravir Ultra Long-acting (CAB ULA) Following Switch From Cabotegravir Long-acting (CAB LA) in Healthy Adults

Who this might be right for
HIV Infections
ViiV Healthcare 69
Not applicableActive Not RecruitingNCT06468995
What this trial is testing

Antiviral Long Acting Drugs Landing in People Living With HIV

Who this might be right for
HIVAntiviral Agents
IRCCS San Raffaele 120
Early research (Phase 1)Study completedNCT05112939
What this trial is testing

A Rilpivirine Extended-Release Suspension in Healthy Participants

Who this might be right for
Healthy
Janssen Research & Development, LLC 126
Not applicableActive Not RecruitingNCT06145854
What this trial is testing

Cisgender Female Patients Who Start on Long Acting Cabotegravir for PrEP

Who this might be right for
Hiv
Midway Specialty Care Center 100
Testing effectiveness (Phase 2)WithdrawnNCT06657885
What this trial is testing

CAbotégravir LENacapavir DUal Long Acting

Who this might be right for
HIV1 InfectionMulti-treated Patients Who Have Received Multiple Lines of Antiretroviral TreatmentCABOTEGRAVIR+2 more
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
Post-approval studies (Phase 4)Study completedNCT05549726
What this trial is testing

SEARCH CAB LA Dynamic Choice HIV Prevention Study Extension

Who this might be right for
HIV
University of California, San Francisco 984
Post-approval studies (Phase 4)Active Not RecruitingNCT05986084
What this trial is testing

Tshireletso: Safety, Efficacy and Feasibility of Cabotegravir-LA PrEP in a Breastfeeding Population in Botswana

Who this might be right for
Pre-Exposure Prophylaxis (PrEP)Breast Feeding
Beth Israel Deaconess Medical Center 500
Testing effectiveness (Phase 2)Study completedNCT01641809
What this trial is testing

Dose Ranging Study of GSK1265744 Plus Nucleoside Reverse Transcriptase Inhibitors for Induction of Human Immunodeficiency Virus-1 (HIV-1) Virologic Suppression Followed by Virologic Suppression Maintenance by GSK1265744 Plus Rilpivirine

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 244
Large-scale testing (Phase 3)Not Yet RecruitingNCT06133686
What this trial is testing

Implementing Oral (Event-driven and Daily) and Long-acting Pre-Exposure Prophylaxis in Mobile Men in Sub-Saharan Africa

Who this might be right for
HIV
MRC/UVRI and LSHTM Uganda Research Unit 400
Not applicableActive Not RecruitingNCT06518408
What this trial is testing

A Real-life Study of the Use of Cabotegravir Plus Rilpivirine Long-acting in ART-experienced Pre-treated People With HIV

Who this might be right for
Human Immunodeficiency Virus
University Hospital Virgen de las Nieves 287
Not applicableNot Yet RecruitingNCT06635421
What this trial is testing

The Expand Study-Pharmacist Administered Long Acting Cabotegravir + Rilpivirine to Expand Access for People With HIV

Who this might be right for
HIV I Infection
MetroHealth Medical Center 164
Large-scale testing (Phase 3)Looking for participantsNCT06134362
What this trial is testing

Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)

Who this might be right for
HIV Infections
ViiV Healthcare 3,508
Early research (Phase 1)Study completedNCT01754116
What this trial is testing

Study to Assess the Relative Bioavailability of New Formulations of GSK1265744 Long Acting Parental (LAP) in Healthy Adult Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 43
Early research (Phase 1)Study completedNCT02059031
What this trial is testing

Assess The Relative Bioavailability of New Tablet Formulations of GSK1265744 in Healthy Adult Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 24
Load More Results